Microarray analysis in Tourette syndrome postmortem putamen

Journal of the Neurological Sciences

Volumn 225, Issue 1-2, 2004, Pages 57-64

  Hong, John J ^a   Loiselle, Christopher R ^a   Yoon, Dustin Y ^a   Lee, Olivia ^a   Becker, Kevin G ^b   Singer, Harvey S ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Clin Ctr Natl Institutes H   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

cDNA microarray; Postmortem tissue; Protein tyrosine phosphatase; Putamen; Tourette syndrome; Z ratio; Z test

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; AUTOPSY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN TISSUE; MENTAL DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT; PUTAMEN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEIN PHOSPHATASE; POSTMORTEM CHANGES; PROTEIN KINASE C; PUTAMEN; R-SNARE PROTEINS; RECEPTORS, AMPA; RECEPTORS, GABA-A; RECEPTORS, GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOURETTE SYNDROME;

EID: 4744361574     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.06.019     Document Type: Article

References (33)

1. H.S. Singer Current issues in Tourette syndrome Mov. Disord. 15 2000 1051 1063
2. H.S. Singer, and K. Minzer Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities Brain Dev. 25 Suppl. 1 2003 S70 S84
3. H.S. Singer, and J.T. Walkup Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment Medicine (Baltimore) 70 1991 15 32
4. H.S. Singer Neurobiology of Tourette syndrome Neurol. Clin. 15 1997 357 379
5. G. Gibson Microarray analysis: genome-scale hypothesis scanning PLoS Biol. 1 2003 E15
6. E. Lehrmann, T.M. Hyde, M.P. Vawter, K.G. Becker, J.E. Kleinman, and W.J. Freed The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia Curr. Mol. Med. 3 2003 437 446
7. K. Mirnics, F.A. Middleton, A. Marquez, D.A. Lewis, and P. Levitt Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex Neuron 28 2000 53 67
8. B. Stoetter, A.R. Braun, C. Randolph, J. Gernert, R.E. Carson, and P. Herscovitch Functional neuroanatomy of Tourette syndrome. Limbic-motor interactions studied with FDG PET Adv. Neurol. 58 1992 213 226
9. m-HMPAO/SPECT in patients with Gilles de la Tourette syndrome-short report Nuclear Medicine: The State of the Art of Nuclear Medicine in Europe 1991 Schattauer Stuttgart 243 245
10. H.S. Singer, A.L. Reiss, J.E. Brown, E.H. Aylward, B. Shih, and E. Chee Volumetric MRI changes in basal ganglia of children with Tourette's syndrome Neurology 43 1993 950 956
11. B.S. Peterson, P. Skudlarski, A.W. Anderson, H. Zhang, J.C. Gatenby, and C.M. Lacadie A functional magnetic resonance imaging study of tic suppression in Tourette syndrome Arch. Gen. Psychiatry 55 1998 326 333
12. L.W. Whitney, K.G. Becker, N.J. Tresser, C.I. Caballero-Ramos, P.J. Munson, and V.V. Prabhu Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays Ann. Neurol. 46 1999 425 428
13. D.J. Duggan, M. Bittner, Y. Chen, P. Meltzer, and J.M. Trent Expression profiling using cDNA microarrays Nat. Genet. 21 1999 10 14
14. T. Barrett, C. Cheadle, W.B. Wood, D. Teichberg, D.M. Donovan, and W.J. Freed Assembly and use of a broadly applicable neural cDNA microarray Restor. Neurol. Neurosci. 18 2001 127 135
15. M.P. Vawter, T. Barrett, C. Cheadle, B.P. Sokolov, W.H. Wood III, and D.M. Donovan Application of cDNA microarrays to examine gene expression differences in schizophrenia Brain Res. Bull. 55 2001 641 650
16. C. Cheadle, M.P. Vawter, W.J. Freed, and K.G. Becker Analysis of microarray data using Z score transformation J. Mol. Diagn. 5 2003 73 81
17. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
18. K. Minzer, O. Lee, J.J. Hong, and H.S. Singer Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum J. Neurol. Sci. 219 2004 55 61
19. D. Miao, L. Yu, C. Tiberti, D.D. Cuthbertson, M. Rewers, and U. di Mario ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies J. Autoimmun. 18 2002 191 196
20. S. Saha, A. Bardelli, P. Buckhaults, V.E. Velculescu, C. Rago, and B. St. Croix A phosphatase associated with metastasis of colorectal cancer Science 294 2001 1343 1346
21. R.Q. Schaapveld, J.T. Schepens, D. Bachner, J. Attema, B. Wieringa, and P.H. Jap Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases, LAR, RPTPdelta and RPTPsigma in the mouse Mech. Dev. 77 1998 59 62
22. P.D. Prasad, V. Torres-Zamorano, R. Kekuda, F.H. Leibach, and V. Ganapathy Functional link between tyrosine phosphorylation and human serotonin transporter gene expression Eur. J. Pharmacol. 325 1997 85 92
23. N. Humblot, L. Esteve, C. Burgun, D. Aunis, and J. Zwiller 5-Hydroxytryptamine induces TIS8/egr-1 and c-fos expression in PC12 cells. Involvement of tyrosine protein phosphorylation Eur. J. Neurosci. 9 1997 84 92
24. S. Paul, G.L. Snyder, H. Yokakura, M.R. Picciotto, A.C. Nairn, and P.J. Lombroso The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway J. Neurosci. 20 2000 5630 5638
25. A.W. Dunah, and D.G. Standaert Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane J. Neurosci. 21 2001 5546 5558
26. N. Bottini, J. MacMurray, M. Rostamkani, M. McGue, W.G. Iacono, and D.E. Comings Association between the low molecular weight cytosolic acid phosphatase gene ACP1*A and comorbid features of Tourette syndrome Neurosci. Lett. 330 2002 198 200
27. P.M. Brett, D. Curtis, M.M. Robertson, and H.M. Gurling The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase Biol. Psychiatry 37 1995 533 540
28. H.S. Singer, L. Oshida, and J.T. Coyle CSF cholinesterase activity in Gilles de la Tourette's syndrome Arch. Neurol. 41 1984 756 757
29. H.S. Singer, I.H. Hahn, E. Krowiak, E. Nelson, and T. Moran Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue Ann. Neurol. 27 1990 443 446
30. H.S. Singer, J. Dickson, D. Martinie, and M. Levine Second messenger systems in Tourette's syndrome J. Neurol. Sci. 128 1995 78 83
31. X. Si, Q. Zeng, C.H. Ng, W. Hong, and C.J. Pallen Interaction of farnesylated PRL-2, a protein-tyrosine phosphatase, with the beta-subunit of geranylgeranyltransferase II J. Biol. Chem. 276 2001 32875 32882
32. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, and A. Rosenwald Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
33. C. Colantuoni, A.E. Purcell, C.M. Bouton, and J. Pevsner High throughput analysis of gene expression in the human brain J. Neurosci. Res. 59 2000 1 10